AAAAAA
Results: 76-86/86
Authors:
WEIR GC
NATHAN DM
SINGER DE
Citation: Gc. Weir et al., STANDARDS OF CARE FOR DIABETES, Diabetes care, 17(12), 1994, pp. 1514-1522
Authors:
GREENFIELD S
KAPLAN SH
SILLIMAN RA
SULLIVAN L
MANNING W
DAGOSTINO R
SINGER DE
NATHAN DM
Citation: S. Greenfield et al., THE USES OF OUTCOMES RESEARCH FOR MEDICAL EFFECTIVENESS, QUALITY OF CARE, AND REIMBURSEMENT IN TYPE-II DIABETES, Diabetes care, 17, 1994, pp. 32-39
Authors:
SINGER DE
Citation: De. Singer, ASPIRIN AND PREVENTION OF STROKE, Lancet, 343(8891), 1994, pp. 233-234
Authors:
ATLAS SJ
SINGER DE
SKATES SJ
Citation: Sj. Atlas et al., CHANGING BLOOD USE IN THE AIDS ERA - THE CASE OF ELECTIVE HIP-SURGERY, Transfusion, 34(5), 1994, pp. 386-391
Authors:
MEIGS JB
SINGER DE
NATHAN DM
CUPPLES LA
WILSON PWF
Citation: Jb. Meigs et al., HEMOGLOBIN A1C RELIABLY REFLECTS GLUCOSE CONTROL OVER 4 TO 6 YEARS AMONG NONDIABETIC SUBJECTS IN THE FRAMINGHAM HEART, Clinical research, 42(2), 1994, pp. 10000246-10000246
Authors:
CARLSON KJ
SKATES SJ
SINGER DE
Citation: Kj. Carlson et al., SCREENING FOR OVARIAN-CANCER, Annals of internal medicine, 121(2), 1994, pp. 124-132
Authors:
CARLSON KJ
SKATES SJ
SINGER DE
Citation: Kj. Carlson et al., SCREENING FOR OVARIAN-CANCER - RECOMMENDATIONS AND RATIONALE, Annals of internal medicine, 121(2), 1994, pp. 141-142
Authors:
HYLEK EM
SINGER DE
Citation: Em. Hylek et De. Singer, RISK-FACTORS FAR INTRACRANIAL HEMORRHAGE IN OUTPATIENTS TAKING WARFARIN, Annals of internal medicine, 120(11), 1994, pp. 897-902
Authors:
SAMET JH
BURSTIN HR
GREEN J
SINGER DE
Citation: Jh. Samet et al., SOCIODEMOGRAPHIC DETERMINANTS IN THE HOSPITALIZATION DECISION - EVALUATION OF AN EMERGENCY DEPARTMENT INTERHOSPITAL TRANSFER POLICY, Annals of emergency medicine, 22(5), 1993, pp. 813-818
Authors:
KISTLER JP
SINGER DE
MILLENSON MM
BAUER KA
GRESS DR
BARZEGAR S
HUGHES RA
SHEEHAN MA
MARAVENTANO SW
OERTEL LB
ROSNER B
ROSENBERG RD
Citation: Jp. Kistler et al., EFFECT OF LOW-INTENSITY WARFARIN ANTICOAGULATION ON LEVEL OF ACTIVITYOF THE HEMOSTATIC SYSTEM IN PATIENTS WITH ATRIAL-FIBRILLATION, Stroke, 24(9), 1993, pp. 1360-1365
Authors:
SINGER DE
Citation: De. Singer, PROBLEMS WITH STOPPING RULES IN TRIALS OF RISKY THERAPIES - THE CASE OF WARFARIN TO PREVENT STROKE IN ATRIAL-FIBRILLATION, Clinical research, 41(3), 1993, pp. 482-486